ArticleScientific reports2025
Multi-omics tests identify novel shared genetic mechanisms of primary biliary cholestasis and sarcopenia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary biliary cholangitis (PBC) may affect skeletal muscles through the muscle-liver axis, subsequently leading to sarcopenia. Our study aims to explore the unclear genetic relationships between PBC and sarcopenia. We investigated the shared genetic architecture of PBC and sarcopenia using advanced statistical genetics methods and genome-wide association summary data. We employed global and local genetic correlation to gain potential shared biological mechanisms. We identified risk single nucleotide polymorphisms (SNPs) and functionally annotated genomic multi-markers by conducting the unified test for molecular signatures. Finally, we prioritized fine-mapping analysis to emphasize the significant causal genes. Our study has identified significant genomic associations, suggesting the complex genetic interactions between PBC and sarcopenia. At the genomic level, we identified 17 unique bivariate regions among 88 trait pairs. In the bivariate locus analysis, we identified a total of 136 pleiotropic loci, with ASTN1, TGFB2, and ACP1 being particularly prominent. Functional enrichment analysis highlighted putative pleiotropic genomic regions, including brain and spleen. Furthermore, the identified pleiotropic loci demonstrate strong signal transduction in the cGMP-PKG signaling pathway. Our findings highlight shared genetic links and causal relationships between PBC and sarcopenia, offering novel insights into their genetic mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.